- Report
- May 2021
- 102 Pages
Global
From €3200EUR$3,549USD£2,834GBP
- Report
- May 2021
- 97 Pages
Global
From €3200EUR$3,549USD£2,834GBP
- Report
- November 2021
- 1112 Pages
Global
From €5795EUR$6,000USD£4,959GBP
- Report
- November 2021
- 545 Pages
Global
From €3863EUR$4,000USD£3,306GBP
- Report
- November 2021
- 233 Pages
Global
From €2415EUR$2,500USD£2,066GBP
- Report
- March 2020
- 108 Pages
Global
From €4346EUR$4,500USD£3,719GBP
- Report
- January 2023
- 256 Pages
Global
From €5534EUR$5,730USD£4,736GBP
- Report
- March 2022
- 210 Pages
Global
From €5572EUR$5,769USD£4,768GBP
- Report
- March 2022
- 230 Pages
Global
From €5572EUR$5,769USD£4,768GBP
- Report
- September 2019
Global
From €5186EUR$5,370USD£4,438GBP
From €3573EUR$3,699USD£3,057GBP
- Book
- January 2024
- 496 Pages
- Book
- October 2020
- 288 Pages
The Digital Polymerase Chain Reaction (dPCR) market is a subset of the genomics industry. It is a technology used to detect and quantify nucleic acid molecules, such as DNA and RNA. It is a highly sensitive and specific method for detecting and quantifying nucleic acid molecules, and is used in a variety of applications, including gene expression analysis, genotyping, and diagnostics. dPCR is also used in research and development, as well as in clinical settings.
dPCR is a cost-effective and efficient method for detecting and quantifying nucleic acid molecules, and is becoming increasingly popular in the genomics industry. It is used in a variety of applications, including gene expression analysis, genotyping, and diagnostics.
Some companies in the dPCR market include Bio-Rad, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and Illumina. Show Less Read more